0001171843-16-013441.txt : 20161130 0001171843-16-013441.hdr.sgml : 20161130 20161130160139 ACCESSION NUMBER: 0001171843-16-013441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161128 FILED AS OF DATE: 20161130 DATE AS OF CHANGE: 20161130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenleaf Peter CENTRAL INDEX KEY: 0001363683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 162025333 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 f4_greenleaf113016.xml OWNERSHIP DOCUMENT X0306 4 2016-11-28 0 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001363683 Greenleaf Peter 805 KING FARM BLVD, SUITE 550 ROCKVILLE MD 20850 0 1 0 0 CEO Common Stock, Class A 2016-11-28 4 M 0 117541 6.75 A 120054 D Common Stock, Class A 2016-11-28 4 S 0 117541 16.91 D 2513 D Common Stock, Class A 2016-11-29 4 M 0 82459 6.75 A 84972 D Common Stock, Class A 2016-11-29 4 S 0 82459 16.75 D 2513 D Employee Stock Option (right to buy) 6.75 2016-11-28 4 M 0 117541 0 D 2015-10-30 2024-09-11 Class A Common Stock 117541 1512459 D Employee Stock Option (right to buy) 6.75 2016-11-29 4 M 0 82459 0 D 2015-10-30 2024-09-11 Class A Common Stock 82459 1430000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.35, inclusive. The reporting person will, upon request, provide any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.75 to $16.78, inclusive. The reporting person will, upon request, provide any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range. /s/ Peter Greenleaf 2016-11-30